In-vitro activity of the new ketolide antibiotic HMR 3647 against Gram-positive bacteria

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 3, 1998, Pages 297-301

  Schulin T ^a,b   Wennersten, C B ^a   Moellering Jr , R C ^a,b   Eliopoulos, G M ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ANTIBIOTIC AGENT; ERYTHROMYCIN; TELITHROMYCIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; CORYNEBACTERIUM DIPHTHERIAE; DILUTION; DRUG POTENCY; ENTEROCOCCUS; ERYSIPELOTHRIX; GRAM POSITIVE BACTERIUM; LACTOBACILLUS; LEUCONOSTOC; LISTERIA MONOCYTOGENES; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEDIOCOCCUS; STAPHYLOCOCCUS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; ERYTHROMYCIN; GRAM-POSITIVE BACTERIA; HUMANS; KETOLIDES; MACROLIDES; MICROBIAL SENSITIVITY TESTS;

EID: 0031713057     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.3.297     Document Type: Article

References (8)

1. Eliopoulos, G. M. (1996). Antibiotic resistance in Enterococcus species: an update. Current Clinical Topics in Infectious Diseases 16, 21-51.
2. Agouridas, C., Benedetti, Y., Denis, A., LeMartret, O. & Chantot, J. F. (1995). Ketolides: a new distinct class of macrolide antibacterials - synthesis and structural characteristics of RU 004. In Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract F157, p. 140. American Society for Microbiology, Washington, DC.
3. Schülin, T., Wennersten, C. B., Moellering, R. C. & Eliopoulos, G. M. (1997). In-vitro activity of RU 64004, a new ketolide antibiotic, against Gram-positive bacteria. Antimicrobial Agents and Chemotherapy 41, 1196-202.
4. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Third Edition: Approved Standard M7-A3. NCCLS, Villanova, PA.
5. B resistance phenotype. Journal of Antimicrobial Chemotherapy 40, 85-90.
6. Jones, R. N. & Biedenbach, D. J. (1997). Antimicrobial activity of RU-66647, a new ketolide. Diagnostic Microbiology and Infectious Diseases 27, 7-12.
7. Agouridas, C., Bonnefoy, A. & Chantot, J. F. (1997). Antibacterial activity of RU 64004 (HMR 3004), a novel ketolide derivative active against respiratory pathogens. Antimicrobial Agents and Chemotherapy 41, 2149-58.
8. Schülin, T., Wennersten, C. B., Moellering, R. C. & Eliopoulos, G. M. (1997). In-vitro activity of HMR 3647 in comparison with erythromycin A against Gram-positive bacteria. In Abstracts of the Thirty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 1997. Abstract F113, p. 165. American Society for Microbiology, Washington, DC.